secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2022-06-09T23:59:59+00:00
Accession:  0001628280-22-016696
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex founder Frank Jaksch resigns as executive director and employee; remains chairman
--------------------------------------------------------------------------------

- Frank L. Jaksch, Jr. resigns as executive director and employee effective June 30, 2022.
- He will continue to serve on the Board as Chairman of the Board.
- Resignation also covers all officer, employee, director roles at subsidiaries.
- Company is ChromaDex Corporation (CDXC).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022016696/0001628280-22-016696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000162828022016696/cdxc-20220603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-016696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer